Leiomyosarcoma of the uterine corpus with ovarian metastases in a 28-year-old woman: case report

A case of invasive leiomyosarcoma of the uterine corpus with right ovarian metastases in a 28-year-old woman is presented. The patient was submitted to surgery including total abdominal hysterectomy with left salpingo-oophorectomy, dissection of the pelvic and paraaortal lymph nodes and fixation of the right ovary to the psoas muscle. Postoperative radiation therapy was applied. A year after treatment, the patient was well.

Leiomyosarcoma uteri; Ovarian metastases; Hysterectomy

[1] Harlow B.L., Weiss N.S., Lofton S.: “The epidemiology of sarcomas of the uterus”. J.N.C.I., 1986, 76, 399.

[2] Silverberg S.G., Major F.J., Blessing J.A. et al.: “Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecologic Oncology Group pathologic study of 203 cases”. Int. J. Gynecol. Pathol., 1990, 9, 1.

[3] Quinn M.A., Anderson M.C., Coulter C.A.E., Souter W.P.: “Malignant disease of the uterus”. In: Shaw R.W., Soutter W.P., Stanston S.L. (eds.), Gynecology, 2nd edn. New York, Churchill Livingstone, 1997, 600.

[4] Berchuck A., Rubin S.C., Hoskins W.J., Saigo P,E., Pierce V.K., Lewis J.L. Jr.: “Treatment of uterine leiomyosarcoma”. Obstet. Gynecol., 1988, 71, 845.

[5] Morice P., Rodrigues A., Pautier P., Rey A., Camatte S., Atallah D. et al.: “Surgery for uterine sarcoma: review of the literature and recommendations for the standard surgical procedure”. Gynecol. Obstet. Fertil., 2003, 31, 147.

[6] Kohorn E.I., Schwartz P.E., Chambers J.T., Peschel A., Kapp D.S., Merino M.: “Adjuvant therapy in mixed mullerian tumors of the uterus”. Gynecol. Oncol., 1986, 23, 212.

[7] DiSaia P.J., Pecorelli S.: “Gynecological sarcomas”. Semin. Surg. Oncol., 1994, 10, 369.

[8] Lurain J.R.: “Uterine cancer”. In: Berek S.J., Adashi E.Y., Hillard P.A. (eds.), Novak’s Gynecology, 12th edn., Baltimore, Williams & Wilkins, 1996, 1094.

[9] El Husseiny G., Al Bareedy N., Mourad W.A., Mohamed G., Shoukri M., Subhi J., Ezzat A.: “Prognostic factors and treatment modalities in uterine sarcoma”. Am. J. Clin. Oncol., 2002, 25, 256.

[10] Singh A.M., Konjengbam R., Devi S.S., Devi N.P.: “Leiomyosarcoma of uterus - a case report”. J. Indian. Med. Assoc., 2006, 104, 142.

[11] Vardi J.R., Tovell H.M.M.: “Leiomyosarcoma of the uterus: clinicopathologic study”. Obstet. Gynecol., 1980, 56, 428.

[12] Van Dinh T.V., Woodruff J.D.: “Leiomyosarcoma of the uterus”. Am. J. Obstet. Gynecol., 1982, 144, 817.

[13] Leitao M.M., Sonoda Y., Brennan M.F., Barakat R.R., Chi D.S.: “Incidence of lymph node and ovarian metastases in leiomyosarcoma of the uterus”. Gynecol. Oncol., 2003, 91, 209.

[14] Moinfar F., Azodi M., Tavassoli F.A.: “Uterine sarcomas”. Pathology, 2007, 39, 55.

[15] Giuntoli R.L., Metzinger D.S., DiMarco C.S., Cha S.S., Sloan J.A., Keeney G.L., Gostout B.S.: “Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy”. Gynecol. Oncol., 2003, 89, 460.

[16] Evans H.L., Chawla S.P., Simpson C., Finn K.P.: “Smooth muscle neoplasms of the uterus other than ordinary leiomyoma: a study of 46 cases, with emphasis on diagnostic criteria and prognostic factors”. Cancer, 1988, 62, 2239.

[17] Olah K.S., Dunn J.A., Gee H.: “Leiomyosarcomas have a poorer prognosis than mixed mesodermal tumours when adjusting for known prognostic factors: the result of a retrospective study of 423 cases of uterine sarcoma”. Br. J. Obstet. Gynaecol., 1992, 99, 590.

[18] Dusenbery K.E., Potish R.A., Judson P.: “Limitations of adjuvant radiotherapy for uterine sarcomas spread beyond the uterus”. Gynecol. Oncol., 2004, 94, 191.